Japan’s Takeda Pharmaceutical Co Ltd plans to sell its consumer health unit for around 400 billion yen ($3.72 billion), Nikkei Business reported.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
